Leads capital deployment across technology and industrials with emphasis on value creation through operational improvements and strategic M&A. Tallon Kerry Patrick brings experience in private equity, corporate development, and capital markets, advising boards on growth financing, carve-outs and integration execution. Background includes deal sourcing, portfolio oversight and executive-level financial management; engages with institutional investors and strategic partners to align exit planning and performance metrics that drive investor returns.
Leads capital deployment across technology and industrials with emphasis on value creation through operational improvements and strategic M&A. Tallon Kerry Patrick brings experience in private equity, corporate development, and capital markets, advising boards on growth financing, carve-outs and integration execution. Background includes deal sourcing, portfolio oversight and executive-level financial management; engages with institutional investors and strategic partners to align exit planning and performance metrics that drive investor returns.
Focuses on hands-on private equity investing that pairs operational value creation with strategic M&A to drive mid-market returns across technology and industrials. Prefers control or significant influence investments where executive-level finance and integration expertise can accelerate margin expansion and top-line scaling. Underwrites deals with rigorous cash-flow analysis, conservative leverage, and KPI-driven governance, targets 3–7 year hold periods, and aligns exit planning with institutional partners to maximize IRR through growth and multiple expansion.
Focuses on hands-on private equity investing that pairs operational value creation with strategic M&A to drive mid-market returns across technology and industrials. Prefers control or significant influence investments where executive-level finance and integration expertise can accelerate margin expansion and top-line scaling. Underwrites deals with rigorous cash-flow analysis, conservative leverage, and KPI-driven governance, targets 3–7 year hold periods, and aligns exit planning with institutional partners to maximize IRR through growth and multiple expansion.
| Trades 105 | Longs Won 76/105 72% | Profit Factor 7.02 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $548,453.02 |
| Average Win $346,967.26 | Best Trade (Oct 15) $3.17M | Sharpe Ratio -729.04 |
| Average Loss -$129,506.86 | Worst Trade (Oct 14) -$1.49M | Z-Score 8.24 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 2w 4d | Expectancy $215,369.64 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 979 | 881 | 784 | 686 | 588 | 490 | 392 | 294 | 196 | 98 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 7434 74348TAT9 | 15,000 | $14,888 | $14,888 | - | - | - | 0.0 |
AAPL Apple Inc. | 7,696 | $1.88M | $2.64M | - | $761,108 | 40.56% | -0.061% |
ABBV AbbVie Inc. | 1,721 | $308,816 | $491,534.64 | - | $182,718.64 | 59.17% | +1.37% |
ABT Abbott Laboratories | 1,767 | $200,448 | $185,393.64 | - | -$15,054.36 | -7.51% | +1.894% |
AMGN Amgen Inc. | 1,041 | $269,910 | $457,228.02 | - | $187,318.02 | 69.4% | +3.077% |
AMZN Amazon.com Inc | 3,635 | $800,500 | $928,524.4 | - | $128,024.4 | 15.99% | +0.535% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 12,778 | $366,473 | $351,267.22 | - | -$15,205.78 | -4.15% | -0.109% |
AQN Algonquin Power & Utilities Corp. | 31,000 | $140,740 | $162,595 | - | $21,855 | 15.53% | +1.845% |
ARKG ARK Genomic Revolution ETF | 26,023 | $636,523 | $1.29M | - | $653,957.57 | 102.74% | +2.713% |
ARKK ARK Innovation ETF Fund | 32,397 | $1.84M | $2.78M | - | $936,575.6 | 50.82% | +1.563% |
ASUR Asure Software Inc. | 144,871 | $1.37M | $1.06M | - | -$310,747.92 | -22.65% | +2.304% |
AVGO Broadcom Inc. | 1,540 | $357,249 | $528,458.7 | - | $171,209.7 | 47.92% | -0.894% |
BCX BlackRock Resources & Commodities Strategy Trust | 13,825 | $120,139 | $167,489.87 | - | $47,350.87 | 39.41% | -0.536% |
BND Vanguard Total Bond Market Index Fund | 6,594 | $474,351 | $467,020.05 | - | -$7,330.95 | -1.55% | +0.604% |
BNL Broadstone Net Lease Inc. | 297,587 | $4.67M | $5.39M | - | $718,675.64 | 15.39% | +0.583% |
BRK-B Berkshire Hathaway Inc. | 6,208 | $2.8M | $3.28M | - | $480,787.08 | 17.17% | +0.41% |
BWX SPDR Bloomberg International Treasury Bond ETF | 13,257 | $281,976 | $282,440.38 | - | $464.38 | 0.16% | +0.59% |
CDLX Cardlytics, Inc. | 1,000 | $37,300 | $2,090 | - | -$35,210 | -94.4% | -1.878% |
CDXS Codexis Inc. | 403,667 | $2.02M | $540,469.75 | - | -$1.48M | -73.22% | +3.791% |
CHRD Chord Energy Corp | 1,717 | $204,134 | $254,528.08 | - | $50,394.08 | 24.69% | +1.409% |